Benign Prostatic Hypertrophy clinical trials

Explore recruiting benign prostatic hypertrophy clinical trials.

Recruiting benign prostatic hypertrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Benign Prostatic Hypertrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SERENDIPITY: phase III multicentric randomized study assessing the reduction of chronic prostate inflammation with Permixon®

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Benign Prostatic Hypertrophy trials by city

Benign Prostatic Hypertrophy in Toronto Benign Prostatic Hypertrophy in Vancouver Benign Prostatic Hypertrophy in Montreal Benign Prostatic Hypertrophy in Calgary Benign Prostatic Hypertrophy in Edmonton Benign Prostatic Hypertrophy in Ottawa Benign Prostatic Hypertrophy in Winnipeg Benign Prostatic Hypertrophy in Quebec City Benign Prostatic Hypertrophy in Hamilton Benign Prostatic Hypertrophy in Kitchener Benign Prostatic Hypertrophy in London Benign Prostatic Hypertrophy in Halifax Benign Prostatic Hypertrophy in New York Benign Prostatic Hypertrophy in Los Angeles Benign Prostatic Hypertrophy in Chicago Benign Prostatic Hypertrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease